Management Team
IDT Biologika is a company of enduring strength, which we recognized with 100th-year anniversary celebrations in 2021. We are privileged to play a role in development and manufacture of the world’s leading vaccines, viral vectors, and therapeutics, which play an ongoing vital role in protecting people and improving quality of life for millions around the world. IDT Biologika has navigated 100 years and continues to bring value to customers as a result of our exceptional people.
Corporate Leadership Team
Dr. Ulrich Valley
Chief Executive Officer
Dr. Ulrich Valley has many years of experience in the pharmaceutical industry and has held various management positions with a focus on Technical Operations, Supply Chain and Development.
He holds a Ph.D. in Biotechnology from the University Of Braunschweig (Germany), where he also received his diploma.
Dr. Sally Choe
Chief Executive Officer
Dr. Sally Choe holds a Master’s and Ph.D. in Pharmaceutics from the University of Michigan, has worked for global pharmaceutical companies such as Pfizer, Bristol-Myers Squibb (BMS) and Parexel Regulatory Consulting firm. She has 12 years of tenure at the U.S. Food and Drug Administration (FDA), where she served as a Deputy Director in the Office of Translational Sciences (OTS) and as Super Office Director of the Office of Generic Drugs (OGD).
Federico Pollano
Chief Commercial Officer
Federico Pollano brings extensive leadership experience from global CDMOs in the pharmaceutical and biotech sectors, with a strong focus on sales management and customer service. He holds a background in biology and extensive expertise in health economics and M&A. His career includes key positions at GSK, Ratiopharm, Polpharma Biologics, Richter-Helm BioTec / Helm Pharmaceuticals, and Rentschler Biopharma.
Dr. Christian Scheer
Senior Vice President Quality
Dr. Christian Scheer has extensive experience in quality management in the pharmaceutical industry. He studied Agriculture at the universities of Göttingen and Gießen, Germany, with a focus on molecular plant genetics, completing his studies at the TU Munich with a PhD in Biochemistry.